首页 | 本学科首页   官方微博 | 高级检索  
     

白细胞介素6和hepcidin在弥漫大B细胞淋巴瘤中的表达及其与贫血的相关性
引用本文:赵建治,周建尧,王国芳,韩晓伟,朱俊岭,孙维栋,侯韬. 白细胞介素6和hepcidin在弥漫大B细胞淋巴瘤中的表达及其与贫血的相关性[J]. 白血病.淋巴瘤, 2017, 26(1). DOI: 10.3760/cma.j.issn.1009-9921.2017.01.012
作者姓名:赵建治  周建尧  王国芳  韩晓伟  朱俊岭  孙维栋  侯韬
作者单位:312030,浙江省绍兴市中心医院血液科;312030,浙江省绍兴市中心医院血液科;312030,浙江省绍兴市中心医院血液科;312030,浙江省绍兴市中心医院血液科;312030,浙江省绍兴市中心医院血液科;312030,浙江省绍兴市中心医院血液科;312030,浙江省绍兴市中心医院血液科
摘    要:
目的:研究白细胞介素6(IL-6)和hepcidin在弥漫大B细胞淋巴瘤(DLBCL)患者中的表达及其在贫血发生中的作用。方法收集诊断时伴或不伴贫血的45例DLBCL患者,在诊断时抽取外周血标本,分别检测IL-6、hepcidin、血清铁蛋白和血红蛋白(Hb)浓度等。以24名健康志愿者作为对照。结果DLBCL患者的血浆hepcidin及IL-6水平分别为(347±171)μg/L、0.27 ng/L(0~9.61 ng/L),与健康对照者的(175±92)μg/L、0相比,差异均有统计学意义(均P<0.001)。在高乳酸脱氢酶(LDH)(P=0.003)、有B症状(P=0.040)和年龄校正的国际预后指数(IPI)评分>1(P=0.010)的患者中血浆hepcidin水平升高,差异均有统计学意义。在男性(P=0.003)、肿瘤分期Ⅲ~Ⅳ期(P=0.008)和IPI评分>1(P=0.004)的DLBCL患者中IL-6水平升高,差异均有统计学意义。 hepcidin水平与血清铁蛋白高度相关(r=0.77,P<0.001),与IL-6弱相关(r=0.31,P=0.030),与Hb无相关性(r=-0.12,P=0.300)。IL-6表达水平与Hb呈负相关(r=-0.35,P=0.009)。多因素分析提示,IL-6可以预测贫血(P=0.03),而hepcidin不能预测贫血(P=0.89)。结论 DLBCL患者血浆hepcidin常高表达,但IL-6水平升高在DLBCL患者贫血的发生中起主要作用。

关 键 词:淋巴瘤  大B-细胞  弥漫性  贫血  白细胞介素6  hepcidin

Expression of interleukin-6 and hepcidin in diffuse large B-cell lymphoma and their relationship with anemia
Zhao Jianzhi,Zhou Jianyao,Wang Guofang,Han Xiaowei,Zhu Junling,Sun Weidong,Hou Tao. Expression of interleukin-6 and hepcidin in diffuse large B-cell lymphoma and their relationship with anemia[J]. Journal of Leukemia & Lymphoma, 2017, 26(1). DOI: 10.3760/cma.j.issn.1009-9921.2017.01.012
Authors:Zhao Jianzhi  Zhou Jianyao  Wang Guofang  Han Xiaowei  Zhu Junling  Sun Weidong  Hou Tao
Abstract:
Objective To study the expression of interleukin-6 (IL-6) and hepcidin in patients with diffuse large B-cell lymphoma (DLBCL) and their significance in anemia. Methods 45 DLBCL patients with or without anemia were analyzed. Peripheral blood samples were collected during diagnosis, and the concentrations of IL-6, hepcidin, serum ferritin and hemoglobin (Hb) were measured. 24 healthy volunteers were collected as controls. Results The levels of plasma hepcidin and IL-6 in patients with DLBCL were (347±171)μg/L and 0.27 ng/L (0-9.61 ng/L), respectively, and compared with those [(175 ± 92)μg/L] and 0 ng/L in healthy controls, the differences were statistically significant (both P<0.001). Plasma hepcidin levels in patients with high lactate dehydrogenase (LDH) (P=0.003), B symptoms (P=0.040) or age-adjusted international prognostic index (IPI)>1 (P=0.010) were increased. The levels of IL-6 in patients of male (P=0.003), stage Ⅲ-Ⅳ (P=0.008) or IPI>1 (P=0.004) were significantly higher. The level of hepcidin was highly correlated with serum ferritin (r=0.77, P<0.001), weakly correlated with IL-6 (r=0.31, P=0.030), and not correlated with Hb (r=-0.12, P=0.3). There was a negative correlation between IL-6 expression and Hb (r=-0.35, P=0.009). Multivariate analysis showed that IL-6 could predict anemia (P=0.03), whereas hepcidin could not (P=0.89). Conclusion The elevated hepcidin level is frequent in DLBCL, and the elevated IL-6 plays the major role in the development of anemia.
Keywords:Lymphoma,large B-cell,diffuse  Anemia  Interleukin-6  Hepcidin
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号